Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Researchers are studying the effectiveness and real-world use of offering a choice of HIV Pre-Exposure Prophylaxis PrEP options through community-based sexual and reproductive health SRH services for adolescents and young adults aged 15 to 30 living in rural South Africa. This trial compares adding long-acting PrEP options like injectable cabotegravir CAB LA and dapivirine vaginal ring, along with post-exposure prophylaxis PEP, to the current standard daily oral PrEP in community settings. The study aims to improve PrEP uptake, retention, and reduce sexually transmissible HIV in this population. Participants in intervention clusters are offered a choice between daily oral tenofoviremtricitabine, injectable CAB LA given every two months, dapivirine vaginal rings changed every three months, or PEP packs. The control clusters receive the standard oral PrEP with integrated community SRH services. Follow-up includes HIV and pregnancy testing, STI management, and peer navigator support to promote adherence. Safety monitoring involves blood tests for liver and kidney function, with visits spaced from monthly to every few months depending on the PrEP method. During the study, participants will have regular assessments including HIV testing every two months, pregnancy testing, STI screening, and blood tests annually. Peer navigators provide psychosocial support and reminders for follow-up visits. Researchers will track PrEP uptake, retention, adherence, HIV incidence, and safety outcomes over 14 months. The study also explores the acceptability, feasibility, and cost-effectiveness of delivering these PrEP options through community-based services. Total study duration extends up to 20 months for some outcome measures.